title: Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea.
authors.affiliation: Division of Endocrinology, Metabolism and Nutrition, Department of Medicine, Duke University, Medical Center, Durham North Carolina, USA.
authors.forename: Lillian F
authors.initials: LF
authors.lastname: Lien
authors.forename: Heather E
authors.initials: HE
authors.lastname: Whitson
authors.forename: Arthur G
authors.initials: AG
authors.lastname: Grant
authors.forename: Diana B
authors.initials: DB
authors.lastname: McNeill
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D044963:Biopsy, Fine-Needle; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary*; D002908:Chronic Disease; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005755:Gastrins / Q000097:blood; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary*; D018761:Multiple Endocrine Neoplasia Type 1 / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D009382:Neoplasms, Unknown Primary; D015282:Octreotide / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D005755:Gastrins; D005765:Gastrointestinal Agents; D015282:Octreotide